Publications by authors named "Emmanuel Fleck"

Claim this Profile
R
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide.
Thomas Systchenko, Laly Nsiala, Arthur Bobin, Hélène Gardeney, Carine Motard, Emmanuel Fleck

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial.
Salomon Manier, Jérôme Lambert, Cyrille Hulin, Margaret Macro, Kamel Laribi, Emmanuel Fleck

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.
Alexis Claudel, Anne-Ségolène Cottereau, Emmanuel Bachy, Emmanuel Itti, Pierre Feugier, Emmanuel Fleck

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waldenström macroglobulinemia and relationship to immune deficiency.
Anthony Levy, Stéphanie Guidez, Céline Debiais, Isabelle Princet, Sabrina Bouyer, Emmanuel Fleck

Leuk Lymphoma· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.
Emilie Cayssials, Jose Torregrosa-Diaz, Pilar Gallego-Hernanz, Florence Tartarin, Thomas Systchenko, Emmanuel Fleck

Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
Stephanie Guidez, Laurence Lacotte-Thierry, Cecile Tomowiak, Isabelle Princet, Brigitte Dreyfus, Emmanuel Fleck

Br J Haematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib weekly 20/56 mg/m , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
Valentine Richez, Cecile Gruchet, Stephanie Guidez, Guillemette Fouquet, Isabelle Azais, Emmanuel Fleck

Am J Hematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis